16|10000|Public
40|$|Hereditary stomatocytosis {{describes}} {{a wide spectrum}} of autosomal dominantly inherited hemolytic disorders in which the basal red cell membrane cation permeability is increased. In this perspective article, Drs. Flatt and Bruce summarize our current knowledge in the field. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 1049...|$|E
40|$|Elevated serum {{ferritin}} {{is found}} in a large spectrum of conditions both genetic and acquired, associated or not with iron overload. In this perspective article, Drs. Camaschella and Poggiali examine our current knowledge of the molecular basis of inherited hyperferritinemia. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 335...|$|E
40|$|The {{combination}} of antithymocyte globulin of horse origin and cyclosporine A {{is the standard}} treatment for aplastic anemia in patients not eligible for bone marrow transplantation. In this perspective article, Drs. Passweg and Tichelli discuss the current immunosuppressive therapy of aplastic anemia. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 348...|$|E
40|$|In this {{perspective}} article, Dr. Cazzola examines standard and novel tools for {{the diagnosis of}} myelodysplastic syndrome. Flow cytometry immunophenotyping may provide complementary information in the diagnostic approach to a patient with this condition. See <b>related</b> <b>articles</b> <b>on</b> <b>pages</b> 1066, 1124 and 1160...|$|R
40|$|The {{apoptotic}} machinery {{has become}} the latest target of vaccinologists attempting to improve the efficacy of DNA vaccines. While workers have previously sought to induce apoptotic death in transfected DCs {{as a means to}} activate immunity, a new approach (see <b>related</b> <b>article</b> <b>on</b> <b>pages</b> 109 – 117) instead seeks to delay apoptosis in host DCs after DNA vaccination...|$|R
40|$|Biphenotypic acute leukemia is rare, necessitating large {{series to}} provide {{information}} on prognosis. In this paper Xu and colleagues review Chinese experience with this conditions. The {{findings of this study}} indicate that the prognosis of biphenotypic acute leukemia patients is poor when compared with de novo acute myeloid leukemia or acute lymphoblastic leukemia. See <b>related</b> perspective <b>article</b> <b>on</b> <b>page</b> 891 and <b>related</b> review <b>article</b> <b>on</b> <b>page</b> 984...|$|R
40|$|Proliferation, differentiation, and {{survival}} of erythroid progenitors are ultimately controlled through activation and repression of specific genetic programs. In this perspective article, Drs. Brandt and Koury examine {{the role of}} LIM domain-only protein 2 (LMO 2) as an important transcriptional regulator in erythropoiesis. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 479...|$|E
40|$|Hematopoietic {{stem cells}} are {{believed}} to reside in {{a limited number of}} specialized niches within the bone marrow. In this perspective article, Drs. Forsberg and Smith-Berdan review the prominent role that cell surface receptors play in integrating extrinsic and intrinsic cues to support effective hematopoiesis. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 1493...|$|E
40|$|From {{the genetic}} standpoint, T-lineage acute lymphoblastic leukemia is a {{heterogeneous}} disease and comprises {{a number of}} different subtypes. In this perspective article, Dr. Mullighan analyzes the relationship between somatic mutations in NOTCH 1 or FBXW 7 and the prognosis of T-lineage acute lymphoblastic leukemia. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 1383...|$|E
40|$|Graft-versus-host disease (GVHD) {{represents}} {{a major cause}} of morbidity and mortality following conventional allogeneic hematopoietic stem cell transplantation (HSCT). A study in mice (see <b>related</b> <b>article</b> <b>on</b> <b>pages</b> 101 – 108) demonstrates that the selective administration of donor memory CD 4 + T cells results in immune reconstitution without GVHD, a result that, if translatable to humans, has important clinical implications for HSCT...|$|R
40|$|Oxygen {{administration}} to premature infants suppresses retinal VEGF expression {{and results in}} the catastrophic vessel loss associated with retinopathy of prematurity. A study investigating {{the development of the}} retinal vasculature in mice (see <b>related</b> <b>article</b> <b>on</b> <b>pages</b> 50 – 57) demonstrates that specific activation of VEGF receptor- 1 by placental growth factor- 1 protects against oxygen-induced vessel loss without stimulating vascular proliferation and neovascularization...|$|R
40|$|Despite longstanding {{evidence}} for increased activation of coagulation in hemolytic anemias, its pathophysiology {{and its role}} in the vaso-occlusive crises of sickle disease remain unclear. Here Dr. Ataga reviews the latest evidence on this topic, emphasizing the likely multifactorial origin of the activation and the increasing {{evidence for}} the importance of cellular elements or their derived microparticles. See <b>related</b> <b>articles</b> <b>on</b> <b>pages</b> 1513 and 152...|$|R
40|$|The high {{prevalence}} of hepatitis C virus infection explains why not negligible proportions {{of candidates for}} hematopoietic stem cell transplantation have this infection. In this perspective article, Dr. Socié and colleagues discuss the clinical problems that derive from hepatitis C virus in transplant recipients. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 249...|$|E
40|$|Acquired {{hemophilia}} is {{much more}} clinically severe than congenital hemophilia, and {{is more difficult to}} diagnose, also because cases are seen in an array of clinical settings that are not usually equipped to tackle them. In this perspective article Drs. Mannucci and Peyvandi examine the management of this condition. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 566...|$|E
40|$|Myeloproliferative {{neoplasms}} {{are characterized}} by overproduction of mature blood cells and increased risk of thromboembolic complications. However, the molecular lesions associated with these disorders also activate circulating blood cells. In this perspective article, Dr. Cervantes and his colleagues examine the role of blood cell activation in the pathophysiology of thrombosis in myeloproliferative neoplasms. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 1537...|$|E
40|$|Hyper-IgM {{syndrome}} (HIGM) is {{a primary}} immunodeficiency characterized by normal to elevated serum levels of IgM and low levels or the absence of IgG, IgA, and IgE. A new study AID expression in nonlymphoid cells (see <b>related</b> <b>article</b> <b>on</b> <b>pages</b> 136 – 142) characterizes HIGM type 4, a previously undocumented defect in antibody gene diversification caused by a selective block in class-switch recombination, providing significant insight towards understanding HIGM immunodeficiencies...|$|R
40|$|In {{this issue}} of the JCI, two reports provide {{intriguing}} new information {{on the role of the}} inflammatory cytokine IL- 6 in breast and lung cancer. The study by Sansone et al. implicates IL- 6 in the instigation of malignant properties in breast cancer stem cells (see the <b>related</b> <b>article</b> beginning <b>on</b> <b>page</b> 3988). The study by Gao et al. identifies mutant variants of EGFR as inducers of IL- 6 in lung adenocarcinomas (see the <b>related</b> <b>article</b> beginning <b>on</b> <b>page</b> 3846). These studies add to our understanding of potential roles for IL- 6 in cancer and further motivate investigations of IL- 6 –targeted chemotherapeutics...|$|R
40|$|After {{successful}} {{treatment of}} malignant diseases, therapy-related myelodysplastic syndrome and {{acute myeloid leukemia}} have emerged as significant problems. This study shows that allogeneic stem cell transplantation can cure {{a significant portion of}} these patients. See <b>related</b> perspective <b>article</b> <b>on</b> <b>page</b> 542...|$|R
40|$|Accumulating {{evidence}} {{has shown that}} marrow failure in some patients with myelodysplastic syndrome is associated with autoimmunity, T-cell mediated myelosuppression and cytokine-induced cytopenias. In this perspective article, Drs. Barrett and Sloand expound on auto-immunity in myelodysplastic syndromes, in particular focusing on what has been learned from study of patients with trisomy 8. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 496...|$|E
40|$|The JAK 2 (V 617 F) {{mutation}} {{is found}} in almost all patients with polycythemia vera and an important fraction of patients with essential thrombocythemia and primary myelofibrosis. This study shows that basophil counts are increased in JAK 2 (V 617 F) -positive patients, and that the basophils contain an increased number of granules. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 1484...|$|E
40|$|The {{pathogenesis}} {{of large}} granular lymphocytic disorders {{is now being}} unravelled. Knowledge of the various cells of origin and the (often viral) drivers of proliferation is emerging. Leukemic transformation involves acquisition of mechanisms to escape death and to continue to proliferate. In this perspective article, Drs. Zambello and Semenzato examine new etiopathogenetic clues as a rationale for innovative therapeutic approaches. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 1407...|$|E
40|$|The {{clinical}} {{behavior of}} follicular lymphoma is largely determined by {{properties of the}} non-malignant tumor microenvironment. The {{results of this study}} suggest that characteristic properties of the microenvironment in follicular lymphoma influence the response to treatment. See <b>related</b> perspective <b>article</b> <b>on</b> <b>page</b> 16...|$|R
40|$|This paper {{shows for}} the first time that {{patients}} with X-linked neutropenia, caused by mutations in the Wiskott Aldrich syndrome gene, developed myelodysplasia/acute myeloid leukemia with acquisition of mutations in the CSF 3 R gene and loss of chromosome 7. See <b>related</b> perspective <b>article</b> <b>on</b> <b>page</b> 1333...|$|R
40|$|There {{are limited}} data on {{survival}} patterns among patients with monoclonal gammopathy of undetermined significance (MGUS). In {{a study of}} 4, 259 MGUS patients, the authors found that individuals diagnosed with MGUS in a clinical setting had a significantly reduced life expectancy. See <b>related</b> perspective <b>article</b> <b>on</b> <b>page</b> 1641...|$|R
40|$|Therapy-related myeloid {{neoplasm}} is {{the term}} recently proposed by the World Health Organization to cover the spectrum of malignant disorders previously described as therapy-related myelodysplastic syndrome or therapy-related acute myeloid leukemia. In this perspective article, Dr. Larson explores the important {{question of whether the}} poor prognosis of these conditions reflects t-MN per se or, rather, associated findings such as complex cytogenetics that are also seen, although less frequently, in de novo myeloid neoplasms. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 542...|$|E
40|$|See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 192. Quality of care {{research}} {{evaluates the}} “degree to whichhealth services {{for individuals and}} populationsincrease the likelihood of desired health outcomes and are consistent with current professional knowledge. 1 Efforts to better understand, measure and influence surgi-cal quality, however, have often been impeded {{by a lack of}} reliable and valid measurements and a failure to control for patient characteristics. 2 Expert panels organized by the RAND group and by Cancer Care Ontario have recom-mended several different quality indicators for prostate can-cer surgery. 3, 4 However, there is very little evidence of the feasibility, reliability and validity of many of the proposed indicators, undermining their application to the quality-of-care process. Surgical margin status as an indicator of quality for prostate cancer care is an interesting example of this dilemma. Th...|$|E
40|$|Oblique 3 D {{view of the}} February-March 2005 {{earthquake}} swarm area on the Endeavour Segment, Juan de Fuca Ridge. See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 14. Masthead Photo—Sampling water from vent Bio 9 ’ at 9 ˚ 50 'N on the East Pacifi c Rise. Courtesy of Karen Von Damm, from January 2002 EPR cruise. On the cover Lau Basin cruise 2 located three new vent fi elds and shared discovery of a fourth fi eld with a Japanese science team in September 2004. PI C. Langmuir deployed ABE, the Autonomous Benthic Explorer, in an innovative three-phased approach from 300 m, 50 m, and 5 to 10 m above bottom to survey water column properties, produce high-resolution bathymetry, and photograph the seafl oor. The microbathymetry of site 1 (above), named “Kilo Moana, ” shows canyons in the seafl oor running north to south, vents lining a scarp, and a 20 -m spire at the same location where water chemistry spikes indicating active venting {{had been found in}} an earlier phase. Site 1 was selected for further study fro...|$|E
40|$|This article decribes {{the results}} of the first European LeukemiaNet working conference on flow cytometry {{immunophenotyping}} in myelodysplastic syndrome. This report is a very comprehensive analysis of the topic, and provides detailed information on what is currently known in the field. See <b>related</b> perspective <b>article</b> <b>on</b> <b>page</b> 1041...|$|R
40|$|The {{classification}} {{and even}} the diagnosis of von Willebrand disease continues to evolve. In this paper, the authors show how a detailed examination of difficult cases using clinical laboratory and molecular analyses {{can be used to}} reach a clinically useful conclusion. See <b>related</b> perspective <b>article</b> <b>on</b> <b>page</b> 610...|$|R
40|$|A T-cell clone, {{identified}} by clonal rearrangement of the T-cell receptor {{and by the}} presence of aberrant T-cell immunophenotype in peripheral blood, defines lymphocytic variant of hypereosinophilic syndrome. This study shows that T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome. See <b>related</b> perspective <b>article</b> <b>on</b> <b>page</b> 1188...|$|R
40|$|Suggested citation: Bergman AB. Studying sudden {{infant death}} {{syndrome}} in a developing country. J Pediatr (Rio J). 2006; 82 : 4 - 5. And this womans child died in the night because she overlaid it and she rose at midnight and took my son from beside me, while thine handmaid slept and laid it on her bosom and laid her dead child on my bosom. I Kings 3 : 19 - 20. Studying {{sudden infant death}} syndrome in a developing country Abraham B. Bergman* See <b>related</b> <b>article</b> <b>on</b> <b>page</b> 21 The biblical quotation above is evidence that children have been dying in their sleep since antiquity, although this phenomenon has been described by several names. Even up to the 1950 s physicians commonly thought that infants dying suddenly and unexpectedly had either smothered in their own bedding, or that an adult had overlaid them. I never heard of crib death during my training in the late 1950 s and early 1960 s. It was not mentioned in pediatric textbooks and no organized research was taking place. That might still be the case today {{were it not for the}} indignation of several American parents who lost infants. They would not accept the veil of ignorance surrounding crib death, nor, more importantly, the absence of any effort to accumulate knowledge about the condition. 1 The advocacy efforts of these parents who formed what was to become the National SIDS Foundation, led to the convening of the First International Conference o...|$|E
40|$|Cyclin D 1 -negative mantle cell {{lymphoma}} {{is difficult}} to distinguish from other small B-cell lymphomas. This study shows that SOX 11 mRNA and nuclear protein expression is a highly specific marker for both cyclin D 1 -positive and negative mantle cell lymphoma. See <b>related</b> perspective <b>article</b> <b>on</b> <b>page</b> 1488...|$|R
40|$|The endothelial protein C {{receptor}} {{plays an}} important role within the protein C pathway in regulating coagulation and inflammation. This study provides information on the mechanisms by which activated protein C causes the release of the endothelial protein C receptor in microparticulate form from endothelial cells. See <b>related</b> perspective <b>article</b> <b>on</b> <b>page</b> 313...|$|R
40|$|Malignant lymphoid {{neoplasms}} carrying both MYC and BCL 2 translocations ("double hit" lymphomas) are uncommon {{and have}} a very aggressive clinical behavior. This thorough study by Tomita and coworkers characterizes a large series of these patients recognizing their poor outcome and frequent extranodal and CNS involvement. See <b>related</b> perspective <b>article</b> <b>on</b> <b>page</b> 894...|$|R
40|$|The {{criteria}} for "biphenotypic acute leukemia" have changed with {{improvements in the}} ability to distinguish blast cells of different lineages. In her perspective on the paper by Xu et al (page 918) Dr. Béné reviews these changes, proceeding up to the most recent WHO classification. See also <b>related</b> review <b>article</b> <b>on</b> <b>page</b> 984...|$|R
40|$|The {{findings}} {{of this study suggest that}} mutant NPM 1, and more specifically the genotype mutant NPM 1 without FLT 3 -ITD, is a predictive factor for response to all-trans retinoic acid given as an adjunct to intensive chemotherapy in older patients with acute myeloid leukemia. See <b>related</b> perspective <b>article</b> <b>on</b> <b>page</b> 10...|$|R
